Our partners in the Netherlands

Universitair Medisch Centrum Groningen (UMCG)

The University Medical Center Groningen is a non-profit educational and research organization, established by virtue of the Dutch Higher Education and Research act. In 2012, the Cancer Research Center Groningen (CRCG) was established within the UMCG. Within the CRCG, The Damage and Repair in Cancer Development and Cancer Treatment (DARE) program is a novel research program. The department of Radiation Oncology has a strong track record in the development and validation of prediction models describing the relationship between complex 3D-dose distributions and the risk of radiation-induced side effects.

For more information go to www.umcg.nl.

Vereniging voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en Patientenzorg (VUMC)

The scientific research carried out at the VU University Medical Center is closely linked to issues that are important both for the hospital itself and for society in general. The aim of research is to expand knowledge (fundamental research) and to apply this knowledge to the health service (strategic and applied research). The Section Biostatistics of the Department of Epidemiology & Biostatistics provides consultation for numerous biological, epidemiological and clinical studies. Moreover, it focuses on methodological research on screening strategies and analysis of genomics data.

For more information go to www.vumc.com.

Stichting Het Nederlands Kanker Instituut – Antoni van Leeuwenhoek ziekenhuis (NKI)

The Netherlands Cancer Institute (NKI) is an independent research institute focusing on cancer research. The NKI works closely together with the Antoni van Leeuwenhoek Hospital (AVL), which provides care and treatment for cancer patients. Together they form a Comprehensive Cancer Centre (OECI accredited). The close interaction between the NKI and the AVL ensures rapid translation of basic finding to new clinical applications.

The research at the Netherlands Cancer Institute covers all aspects of cancer research, from basic research, via translational research to clinical trials (the latter performed in collaboration with the AVL). The NKI has a strong basic and translational research activity in the areas of genetics, (micro)biology, biochemistry, immunology and epidemiology. The NKI offers an open, collaborative, but critical surrounding in which scientific excellence is stimulated. The open atmosphere makes that scientist within the Institute help each other with reagents, ideas and critical comments. This has resulted in international recognition of the NKI as one of the best places for cancer research.

For more information go to www.nki.nl.